Publications
812
Citations
58,505
Est. group size
~36
Recurring co-author estimate
Active years
28
Publishing since 1999
Typically publishes in teams of ~11 · 10% small-team papers (≤3 authors) · across 75 venues
- Autoantibody associations in patients with early diffuse cutaneous systemic sclerosis: the prospective registry of early systemic sclerosis
Seminars in Arthritis and Rheumatism · 2026
- CCN3-derived peptide BLR-200 impairs YAP activation and attenuates bleomycin-induced skin fibrosis through blocking the generation of Sfrp2-positive fibroblasts
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Phase II randomised, double-blind, placebo-controlled, dose-ranging study of nemolizumab with an extension period in adult patients with systemic sclerosis: THESSALIA study design and rationale
Journal of Scleroderma and Related Disorders · 2026
- Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics
Journal of Clinical Medicine · 2025
- Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study
The Lancet Rheumatology · 2025
- Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA
The Lancet Rheumatology · 2025
- Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trial
The Lancet Rheumatology · 2025
- Continued nintedanib in patients with systemic sclerosis-associated interstitial lung disease: 3-year data from SENSCIS-ON
RMD Open · 2025
- Geographic Clustering of Systemic Sclerosis in Areas of Environmental Pollution
Arthritis Care & Research · 2025
- Comparative Efficacy of Immunosuppressive Therapies in the Treatment of Diffuse Cutaneous Systemic Sclerosis
ACR Open Rheumatology · 2025
- Trajectories of forced vital capacity in patients with systemic sclerosis-associated interstitial lung disease
Arthritis Research & Therapy · 2025
- Management of disease progression after autologous hematopoietic stem cell transplantation in systemic sclerosis: Results from an international questionnaire-based study
Seminars in Arthritis and Rheumatism · 2025
- Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis
The Journal of Rheumatology · 2025
- Physician–patient communication in the treatment of systemic sclerosis–associated interstitial lung disease: A narrative review and recommendations
Journal of Scleroderma and Related Disorders · 2025
- Impact of Scleroderma‐Associated Autoantibodies on Clinical Outcome Assessments: Post Hoc Analysis From a Randomised, Double‐blind, Placebo‐controlled, Phase 3 Trial of Tocilizumab in Scleroderma
ACR Open Rheumatology · 2025
- Annals of the Rheumatic Diseases×81
- Lara D. Veeken×47
- Arthritis & Rheumatology×44
- Journal of Scleroderma and Related Disorders×28
- Arthritis Care & Research×23
- Suiyuan Huang
Medicine · University of Michigan
- Dinesh Khanna
Medicine · University of Michigan
- Carleigh Zahn
Medicine · University of Michigan
- John Varga
Medicine · University of Michigan
- Alain Lescoat
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile